• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN Back to Search Results
Catalog Number 03737551190
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/15/2020
Event Type  malfunction  
Manufacturer Narrative
Upon review of calibration data, the customer's calibration signals were acceptable, although signals are somewhat below the expected signal ranges.Quality controls were acceptable.Upon review of the alarm trace, no relevant alarms occurred on the day of the event.Performance testing was run on the analyzer and this failed.The investigation could not identify a product problem.The cause of the event could not be determined.
 
Manufacturer Narrative
The reporter deleted the ferritin application from the analyzer, then loaded a new reagent lot number (431645) and ran calibration and controls.This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for five patient samples tested with elecsys ferritin on a cobas e 411 immunoassay analyzer and a second elecsys system at another site.The values did not compare to those measured on a vidas system.The reporter believe the values from the vidas system and the elecsys analyzer at the second site to be correct.The model of the elecsys analyzer used at the customer site was requested, but not provided.This analyzer is either an e411 analyzer or a cobas 6000 e 601 module.For the first three samples, no incorrect results were reported outside of the laboratory.For the fourth and fifth samples, it was asked, but it is not known if any incorrect values were reported outside of the laboratory.The first sample initially resulted with a ferritin value of 11.96 ng/ml accompanied by a data flag when tested on the customer's e411 analyzer.The sample was repeated on a vidas analyzer, resulting with a value of 1.5 ng/ml.The sample was tested on an unknown elecsys analyzer at a second site on 16-jan-2020, resulting with a ferritin value of 2.7 ng/ml.A value of 1.7 ng\ml was also provided as a measurement obtained on the elecsys analyzer at the second site.It was asked, but it is not known if this is an additional value from the elecsys analyzer or if it replaces the provided value of 2.7 ng/ml.The second sample, from a female patient, initially resulted with a ferritin value of 51.28 ng/ml when tested on the customer's e411 analyzer.The sample was repeated on a vidas analyzer, resulting with a value of 29.83 ng/ml.The third sample, from a female patient, initially resulted with a ferritin value of 61.19 ng/ml when tested on the customer's e411 analyzer.The sample was repeated on a vidas analyzer, resulting with a value of 33.8 ng/ml.The fourth sample, from a female patient, initially resulted with a ferritin value of 3.56 ng/ml when tested on the customer's e411 analyzer.When tested on the elecsys analyzer at the second site, the sample resulted with a value of 1.54 ng/ml.The fifth sample, from a female patient, initially resulted with a ferritin value of 21.46 ng/ml when tested on the customer's e411 analyzer.When tested on the elecsys analyzer at the second site, the sample resulted with a value of 15.6 ng/ml.The serial number of the customer's e411 analyzer is (b)(4).The serial number of the elecsys analyzer used at the second site was requested, but not provided.
 
Manufacturer Narrative
For sample 1, the correct repeat value from the unknown elecsys analyzer at a second site on (b)(6) 2020 was confirmed as 2.7 ng/ml.The 1.7 ng/ml value is to be disregarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FERRITIN
Type of Device
RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9720240
MDR Text Key189569471
Report Number1823260-2020-00470
Device Sequence Number1
Product Code JMG
Combination Product (y/n)N
PMA/PMN Number
K971833
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 04/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Catalogue Number03737551190
Device Lot Number36646401
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/24/2020
Initial Date FDA Received02/18/2020
Supplement Dates Manufacturer Received01/24/2020
01/24/2020
Supplement Dates FDA Received02/20/2020
04/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-